Sulfinpyrazone kinetics after intravenous and oral administration. 1979

J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias

Sulfinpyrazone kinetics has been investigated after intravenous and oral doses. They may be described by a 3-compartment open model. In the body about half the drug is in the plasma or in interstitial fluids, which equilibrated with plasma. Most of the rest is in an extravascular compartment, from which it easily diffuses back to the plasma. About 3% of the dose is still in the body after 24 hr and is located mainly in a deep compartment. After oral administration, sulfinpyrazone is quickly absorbed, largely from the stomach.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone

Related Publications

J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
November 1982, Clinical pharmacology and therapeutics,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
January 1987, European journal of clinical pharmacology,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
September 1981, Antimicrobial agents and chemotherapy,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
April 1982, Klinische Wochenschrift,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
January 1981, Journal de pharmacie de Belgique,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
January 1981, Journal de pharmacie de Belgique,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
January 1982, Cancer chemotherapy and pharmacology,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
April 1990, Biopharmaceutics & drug disposition,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
April 1983, Clinical pharmacology and therapeutics,
J B Lecaillon, and C Souppart, and J P Schoeller, and G Humbert, and P Massias
October 1985, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!